Enhancing Outcomes and Reducing Treatment Burden with Advanced Therapies in Neovascular AMD and DME
home / viewpoints / enhancing-outcomes-and-reducing-treatment-burden-with-advanced-therapies-in-neovascular-amd-and-dme
EP. 1: Evolution of Anti-VEGF Agents and Unmet Needs in Retinal Diseases
December 20th 2024Panelists discuss how anti-VEGF therapies have dramatically improved visual outcomes in patients with age-related macular degeneration and diabetic macular edema over the past decade. Key challenges persist, including treatment burden, adherence, and identifying optimal dosing regimens for individual patients.
